American Renal Associates Holdings Inc (NYSE:ARA) Receives $13.37 Consensus Target Price from Brokerages

Shares of American Renal Associates Holdings Inc (NYSE:ARA) have earned an average rating of “Hold” from the nine ratings firms that are presently covering the company, Marketbeat reports. Eight equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $13.37.

Several brokerages have issued reports on ARA. Barclays set a $7.00 target price on shares of American Renal Associates and gave the stock a “hold” rating in a report on Friday, April 26th. ValuEngine raised shares of American Renal Associates from a “sell” rating to a “hold” rating in a report on Tuesday, July 2nd.

Hedge funds have recently made changes to their positions in the company. Private Asset Management Inc. bought a new stake in shares of American Renal Associates in the second quarter worth approximately $115,000. SG Americas Securities LLC bought a new stake in shares of American Renal Associates in the second quarter worth approximately $121,000. Squarepoint Ops LLC bought a new stake in shares of American Renal Associates in the fourth quarter worth approximately $125,000. Adams Diversified Equity Fund Inc. grew its stake in shares of American Renal Associates by 24.7% in the second quarter. Adams Diversified Equity Fund Inc. now owns 22,239 shares of the company’s stock worth $165,000 after acquiring an additional 4,400 shares during the period. Finally, Strs Ohio grew its stake in shares of American Renal Associates by 88.7% in the first quarter. Strs Ohio now owns 60,000 shares of the company’s stock worth $368,000 after acquiring an additional 28,200 shares during the period. Hedge funds and other institutional investors own 89.88% of the company’s stock.

American Renal Associates stock traded down $0.13 during trading hours on Monday, hitting $7.26. The stock had a trading volume of 98,463 shares, compared to its average volume of 147,465. The company has a market cap of $236.10 million, a PE ratio of 11.32 and a beta of 1.93. American Renal Associates has a 12-month low of $5.48 and a 12-month high of $23.99. The stock has a 50-day simple moving average of $7.13.

American Renal Associates Company Profile

American Renal Associates Holdings, Inc operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease.

Featured Article: Earnings Per Share

Analyst Recommendations for American Renal Associates (NYSE:ARA)

Receive News & Ratings for American Renal Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates and related companies with MarketBeat.com's FREE daily email newsletter.